| REGISTERED NUMBER: |
| STRATEGIC REPORT, REPORT OF THE DIRECTORS AND |
| FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| FOR |
| SYCHEM LIMITED |
| REGISTERED NUMBER: |
| STRATEGIC REPORT, REPORT OF THE DIRECTORS AND |
| FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| FOR |
| SYCHEM LIMITED |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| CONTENTS OF THE FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| Page |
| Company Information | 1 |
| Strategic Report | 2 |
| Report of the Directors | 4 |
| Report of the Independent Auditor | 6 |
| Income Statement | 10 |
| Other Comprehensive Income | 11 |
| Balance Sheet | 12 |
| Statement of Changes in Equity | 13 |
| Notes to the Financial Statements | 14 |
| SYCHEM LIMITED |
| COMPANY INFORMATION |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| DIRECTORS: |
| SECRETARY: |
| REGISTERED OFFICE: |
| BUSINESS ADDRESS: |
| REGISTERED NUMBER: |
| AUDITOR: |
| Sutherland House |
| 1759 London Road |
| Leigh On Sea |
| Essex |
| SS9 2RZ |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| STRATEGIC REPORT |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| The directors present their strategic report for the year ended 31 December 2024. |
| Sychem Limited is a private limited company based in the UK that specializes in providing disinfection, sterilization, and decontamination solutions. With over 40 years of experience, the company serves a range of sectors, including healthcare, pharmaceuticals, and laboratories. Sychem's business model revolves around a comprehensive, end-to-end approach, which includes the supply of capital equipment (such as autoclaves and washer-disinfectors), specialist chemicals, and consumables, as well as providing UKAS-accredited validation, maintenance, and aftersales support. |
| FAIR REVIEW OF BUSINESS |
| Market constraints made the market for capital projects challenging for Sychem throughout the year however, the need for maintenance and service by its customers increased during the year. |
| With the variability of capital projects the business has made it's key focus on the growth of it's service offerings in all of the market place that it is active in. |
| PRINCIPAL RISKS AND UNCERTAINTIES |
| Regulatory risk |
| The group's products and machines are manufactured to the highest quality standards to maintain industry accreditations and comply with all relevant laws and licenses. |
| Quality management is therefore a key priority for the business and regular monitoring is carried out. Any failings could lead to litigation and reputational damage. |
| The company has rigorous recruitment procedures to ensure technical staff and engineers have the appropriate qualifications and experience. Ongoing training programmes are in place. |
| Economic conditions and government policy |
| Customer appetite for capital investment will be partly influenced by macro economic factors such as interest rates, availability of finance, political stability and government tax policy. |
| The company manages its exposure to foreign exchange fluctuations by taking out hedging contracts where suitable. |
| Competition |
| The company remains ever alert to new entrants to the market. |
| The company prides itself on its reputation with customers and suppliers and by maintaining good relations throughout the supply chain, the group is able to offer an excellent level of service to clients thereby ensuring repeat custom. |
| Bank funding |
| The company does utilise bank funding for capital investment or short term working capital requirements. It maintains a good relationship with the bank and ensures that it meets it obligations under any covenant agreements. |
| FUTURE DEVELOPMENTS |
| The company will continue to work with it's extensive customer base to deliver capital projects, repair services and consumables. The residual supply of medical equipment left over from the closure of a fellow subsidiary, Sychem Surgical Limited, has been transferred to Sychem Ltd during the period since the balance sheet date. . |
| Sychem continues to look for opportunities to drive growth and expand its operations in strategic locations. |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| STRATEGIC REPORT |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| KEY PERFORMANCE INDICATORS |
| The key performance indicators of the company are: |
| Turnover decreased by 16% |
| Gross profit margin 52% (2023: 48%) |
| EBITDA - loss - £301,656 (2023: Profit- £747,119) |
| Shareholders funds decreased by 29% |
| ON BEHALF OF THE BOARD: |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| REPORT OF THE DIRECTORS |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| The directors present their report with the financial statements of the company for the year ended 31 December 2024. |
| PRINCIPAL ACTIVITY |
| The principal activity of the company in the year under review was that of sale and service of equipment to the medical and laboratory industries |
| DIVIDENDS |
| No interim dividends were paid during the year on any of the shares. |
| No dividends will be distributed for the year ended 31 December 2024. |
| DIRECTORS |
| The directors shown below have held office during the whole of the period from 1 January 2024 to the date of this report. |
| Other changes in directors holding office are as follows: |
| STATEMENT OF DIRECTORS' RESPONSIBILITIES |
| The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations. |
| Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to: |
| - | select suitable accounting policies and then apply them consistently; |
| - | make judgements and accounting estimates that are reasonable and prudent; |
| - | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
| The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. |
| STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
| So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditor is unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditor is aware of that information. |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| REPORT OF THE DIRECTORS |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| AUDITOR |
| The auditor, affinia, will be proposed for re-appointment at the forthcoming Annual General Meeting. |
| ON BEHALF OF THE BOARD: |
| REPORT OF THE INDEPENDENT AUDITOR TO THE MEMBERS OF |
| SYCHEM LIMITED |
| Qualified opinion |
| I have audited the financial statements of Sychem Limited (the 'company') for the year ended 31 December 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice). |
| In our opinion, except for the possible effect on the corresponding figures of the matters described in the Basis for Qualified Opinion paragraph, the financial statements: |
| - give a true and fair view of the state of the company's affairs as at 31st December 2024 and of its profit for the year then ended; |
| - have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
| - have been prepared in accordance with the requirements of the Companies Act 2006 . |
| Basis for qualified opinion |
| We were not appointed as auditor of the company until after 31 December 2022 and thus did not observe the counting of physical inventories or verify the status and condition of work in progress on projects as at the end of that year. We were unable to satisfy ourselves by alternative means concerning the inventory quantities of £957,133 held at 31st December 2022 by using other audit procedures. |
| We were therefore unable to determine whether there was any consequential effect on the cost of sales for the year ended 31st December 2023. Our audit opinion on the financial statements for the period ended 31st December 2023 was modified accordingly. Our opinion on the current period's financial statements is also modified because of the possible effect of this matter on the comparability of the current period's figures and the corresponding figures. |
| We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified opinion. |
| Conclusions relating to going concern |
| In auditing the financial statements, I have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. |
| Based on the work I have performed, I have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. |
| My responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report. |
| Other information |
| The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and my Report of the Auditor thereon. |
| My opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in my report, I do not express any form of assurance conclusion thereon. |
| In connection with my audit of the financial statements, my responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or my knowledge obtained in the audit or otherwise appears to be materially misstated. If I identify such material inconsistencies or apparent material misstatements, I am required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work I have performed, I conclude that there is a material misstatement of this other information, I am required to report that fact. I have nothing to report in this regard. |
| REPORT OF THE INDEPENDENT AUDITOR TO THE MEMBERS OF |
| SYCHEM LIMITED |
| Opinions on other matters prescribed by the Companies Act 2006 |
| In my opinion, based on the work undertaken in the course of the audit: |
| - | the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and |
| - | the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements. |
| Matters on which I am required to report by exception |
| In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, I have not identified material misstatements in the Strategic Report or the Report of the Directors. |
| In respect solely of the limitation on our work relating to corresponding figures referred to above: |
| - we have not obtained all the information and explanations that we considered necessary for the purpose of our audit; and |
| - we were unable to determine whether adequate accounting records had been maintained. |
| We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: |
| - returns adequate for our audit have not been received from branches not visited by us; or |
| - the financial statements are not in agreement with the accounting records and returns; or |
| - certain disclosures of directors' remuneration specified by law are not made. |
| - the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption from the requirement to prepare a Strategic Report or in preparing the Report of the Directors. |
| Responsibilities of directors |
| As explained more fully in the Statement of Directors' Responsibilities set out on page four, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. |
| In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so. |
| REPORT OF THE INDEPENDENT AUDITOR TO THE MEMBERS OF |
| SYCHEM LIMITED |
| Auditor's responsibilities for the audit of the financial statements |
| My objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditor that includes my opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. |
| The extent to which my procedures are capable of detecting irregularities, including fraud is detailed below: |
| We obtained an understanding of the legal and regulatory framework applicable to the entity through written and verbal communication. In addition, we drew on our professional knowledge of the industry to aid our understanding. |
| We obtained an understanding of the systems in place designed to ensure compliance with the relevant legislation and evaluated whether these are sufficient or alternatively whether the risk of non-compliance is heightened. We also made specific enquiries of management and those charged with governance as to whether there have been any known instances of non-compliance and the results of their risk assessment. |
| We briefed the identified laws and regulations to our audit team, ensuring they are aware of those considered significant in nature. At the same time, the responsible individual considered whether the engagement team has the collective competence to recognise non-compliance with laws and regulations. |
| The company's financial statements are directly affected by company law, applicable financial reporting standards and tax legislation. Our audit tests are designed to provide sufficient expectation that we will highlight instances of non-compliance. |
| Owing to the nature of the entity's trade, we have identified that non-compliance with specific legislation has the potential to materially affect the disclosures in the financial statements by way of litigation or fines and penalties. Such legislation includes GDPR, employment and health and safety legislation. |
| In addition to holistically considering where and how fraud may occur within the company, the following specific procedures were also undertaken: |
| - Scrutinising journal entries, in particular those crediting cash or a revenue account; journal entries with unusual nominal combinations or journal entries posted by management; |
| - Evaluating assumptions made by management, in particular where these involve material accounting estimates; |
| - Making sure our samples include an appropriate number of random of entries selected on a random basis; |
| - Undertaking analytical procedures with a view to identifying unusual movements in account balances which could be indicative of fraud. |
| We did not identify nor do we suspect any material fraudulent activity having undertaken the above procedures. |
| Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation. |
| A further description of my responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of my Report of the Auditor. |
| REPORT OF THE INDEPENDENT AUDITOR TO THE MEMBERS OF |
| SYCHEM LIMITED |
| Use of my report |
| This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. My audit work has been undertaken so that I might state to the company's members those matters I am required to state to them in a Report of the Auditor and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the company and the company's members as a body, for my audit work, for this report, or for the opinions I have formed. |
| for and on behalf of |
| Sutherland House |
| 1759 London Road |
| Leigh On Sea |
| Essex |
| SS9 2RZ |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| INCOME STATEMENT |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| 2024 | 2023 |
| Notes | £ | £ | £ | £ |
| TURNOVER | 3 |
| Cost of sales |
| GROSS PROFIT |
| Distribution costs |
| Administrative expenses |
| 5,710,674 | 5,308,584 |
| OPERATING (LOSS)/PROFIT | 5 | ( |
) |
| Interest receivable and similar income |
| (299,820 | ) | 748,979 |
| Interest payable and similar expenses | 7 |
| (LOSS)/PROFIT BEFORE TAXATION | ( |
) |
| Tax on (loss)/profit | 8 | ( |
) |
| (LOSS)/PROFIT FOR THE FINANCIAL YEAR |
( |
) |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| OTHER COMPREHENSIVE INCOME |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| 2024 | 2023 |
| Notes | £ | £ |
| (LOSS)/PROFIT FOR THE YEAR | ( |
) |
| OTHER COMPREHENSIVE INCOME | - | - |
| TOTAL COMPREHENSIVE INCOME FOR THE YEAR |
( |
) |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| BALANCE SHEET |
| 31 DECEMBER 2024 |
| 2024 | 2023 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Intangible assets | 9 |
| Tangible assets | 10 |
| CURRENT ASSETS |
| Stocks | 11 |
| Debtors | 12 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 13 |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
14 |
( |
) |
( |
) |
| PROVISIONS FOR LIABILITIES | 18 | ( |
) | ( |
) |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital | 19 |
| Retained earnings | 20 |
| SHAREHOLDERS' FUNDS |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| STATEMENT OF CHANGES IN EQUITY |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| Called up |
| share | Retained | Total |
| capital | earnings | equity |
| £ | £ | £ |
| Balance at 1 January 2023 |
| Changes in equity |
| Total comprehensive income | - |
| Balance at 31 December 2023 |
| Changes in equity |
| Issue of share capital | ( |
) | - | ( |
) |
| Total comprehensive income | - | ( |
) | ( |
) |
| Balance at 31 December 2024 |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| NOTES TO THE FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| 1. | STATUTORY INFORMATION |
| Sychem Limited is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Financial Reporting Standard 102 - reduced disclosure exemptions |
| The company has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland": |
| • | the requirements of Section 7 Statement of Cash Flows. |
| Significant judgements and estimates |
| In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. |
| The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods. |
| Turnover |
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| Goodwill |
| Research & development |
| Research & Development costs are capitalised and amortised over the anticipated earning period of the technology commencing in the year in which the first revenues are received |
| Tangible fixed assets |
| Plant and machinery | - |
| Fixtures and fittings | - |
| Motor vehicles | - |
| Free on Loan | - |
| Stocks |
| Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
| Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition. |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| 2. | ACCOUNTING POLICIES - continued |
| Financial instruments |
| The company has elected to apply the provisions of Section 11 "Basic Financial Instruments" and Section 12 "Other Financial Instruments Issues" of FRS 102 to all its financial instruments. |
| Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. |
| Basic financial assets: |
| Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. |
| Basic financial liabilities: |
| Basic financial liabilities, including creditors, bank loans, loans from fellow group companies that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financing liabilities classified as payable within one year are not amortised. |
| Debt instruments are subsequently carried at amortised cost, using the effective rate of interest. |
| Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment due within one year or less. If not they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| 2. | ACCOUNTING POLICIES - continued |
| Hire purchase and leasing commitments |
| Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter. |
| The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability. |
| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. |
| Pension costs and other post-retirement benefits |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| Contract revenue and work-in-progress |
| Contract revenue is recognised when the revenue can be separated from the sale of goods and the outcome of the contract can be estimated reliably. Costs initially incurred securing the contract are expensed to the profit and loss account. |
| The extent to which contract revenue is recognised is dependent upon the stage of completion. The company recognises revenue based on the physical proportion of the contact completed. At such time this cannot be measured reliably, the company recognises revenue to the extent contract costs are incurred. |
| Amounts due from customers for contract work is recorded as work-in-progress and included within trade and other debtors. Amounts due to customers for contract work is recorded as deferred income and included in trade and other creditors. |
| 3. | TURNOVER |
| The turnover and loss (2023 - profit) before taxation are attributable to the one principal activity of the company. |
| An analysis of turnover by class of business is given below: |
| 2024 | 2023 |
| £ | £ |
| 4. | EMPLOYEES AND DIRECTORS |
| 2024 | 2023 |
| £ | £ |
| Wages and salaries |
| Social security costs |
| Other pension costs |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| 4. | EMPLOYEES AND DIRECTORS - continued |
| The average number of employees during the year was as follows: |
| 2024 | 2023 |
| Employees |
| 2024 | 2023 |
| £ | £ |
| Directors' remuneration |
| Directors' pension contributions to money purchase schemes |
| The number of directors to whom retirement benefits were accruing was as follows: |
| Money purchase schemes |
| Information regarding the highest paid director is as follows: |
| 2024 | 2023 |
| £ | £ |
| Emoluments etc |
| Pension contributions to money purchase schemes |
| 5. | OPERATING (LOSS)/PROFIT |
| The operating loss (2023 - operating profit) is stated after charging/(crediting): |
| 2024 | 2023 |
| £ | £ |
| Hire of plant and machinery |
| Other operating leases |
| Depreciation - owned assets |
| Depreciation - assets on hire purchase contracts |
| (Profit)/loss on disposal of fixed assets | ( |
) |
| Goodwill amortisation |
| Auditors' remuneration |
| Auditors' remuneration for non audit work |
| 6. | EXCEPTIONAL ITEMS |
| 2024 | 2023 |
| £ | £ |
| Loan write off | (66,130 | ) | (5,882 | ) |
| In the prior year a loan to the value of £5,882 due from a company under the common control of one of the company's directors was written off. |
| In the year a loan to the value of £66,130 due from a group company was written off. |
| 7. | INTEREST PAYABLE AND SIMILAR EXPENSES |
| 2024 | 2023 |
| £ | £ |
| Hire purchase |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| 8. | TAXATION |
| Analysis of the tax (credit)/charge |
| The tax (credit)/charge on the loss for the year was as follows: |
| 2024 | 2023 |
| £ | £ |
| Current tax: |
| UK corporation tax |
| Deferred tax | ( |
) |
| Tax on (loss)/profit | ( |
) |
| 9. | INTANGIBLE FIXED ASSETS |
| Patents |
| and | Development |
| Goodwill | licences | costs | Totals |
| £ | £ | £ | £ |
| COST |
| At 1 January 2024 |
| and 31 December 2024 |
| AMORTISATION |
| At 1 January 2024 |
| Amortisation for year |
| At 31 December 2024 |
| NET BOOK VALUE |
| At 31 December 2024 |
| At 31 December 2023 |
| 10. | TANGIBLE FIXED ASSETS |
| Fixtures |
| Plant and | and | Motor | Free on |
| machinery | fittings | vehicles | Loan | Totals |
| £ | £ | £ | £ | £ |
| COST |
| At 1 January 2024 |
| Additions |
| Disposals | ( |
) | ( |
) | ( |
) |
| At 31 December 2024 |
| DEPRECIATION |
| At 1 January 2024 |
| Charge for year |
| Eliminated on disposal | ( |
) | ( |
) | ( |
) |
| At 31 December 2024 |
| NET BOOK VALUE |
| At 31 December 2024 |
| At 31 December 2023 |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| 10. | TANGIBLE FIXED ASSETS - continued |
| Fixed assets, included in the above, which are held under hire purchase contracts are as follows: |
| Motor |
| vehicles |
| £ |
| COST |
| At 1 January 2024 |
| Disposals | ( |
) |
| At 31 December 2024 |
| DEPRECIATION |
| At 1 January 2024 |
| Charge for year |
| Eliminated on disposal | ( |
) |
| At 31 December 2024 |
| NET BOOK VALUE |
| At 31 December 2024 |
| At 31 December 2023 |
| 11. | STOCKS |
| 2024 | 2023 |
| £ | £ |
| Stocks |
| Work-in-progress |
| 12. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Trade debtors |
| Amounts owed by group undertakings |
| Other Debtors |
| Rent deposit | - | 4,450 |
| Sundry debtors | 3,000 | - |
| Purchase ledger debit balances | - | 1,215 |
| Related non-group loan account | - | 621,914 |
| Accrued income |
| Prepayments |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| 13. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Bank loans and overdrafts (see note 15) |
| Hire purchase contracts (see note 16) |
| Trade creditors |
| Amounts owed to group undertakings |
| Tax |
| Social security and other taxes |
| Pension Creditor | 17,505 | 15,851 |
| Sales ledger credit balances | - | 39,681 |
| VAT | 186,624 | 292,833 |
| Other creditors |
| Directors' current accounts | - | 33,745 |
| Deferred Income |
| Accrued expenses |
| 14. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Hire purchase contracts (see note 16) |
| 15. | LOANS |
| An analysis of the maturity of loans is given below: |
| 2024 | 2023 |
| £ | £ |
| Amounts falling due within one year or on demand: |
| Bank overdrafts |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| 16. | LEASING AGREEMENTS |
| Minimum lease payments fall due as follows: |
| Hire purchase |
| contracts |
| 2024 | 2023 |
| £ | £ |
| Gross obligations repayable: |
| Within one year |
| Between one and five years |
| Finance charges repayable: |
| Within one year |
| Between one and five years |
| Net obligations repayable: |
| Within one year |
| Between one and five years |
| Non-cancellable |
| operating leases |
| 2024 | 2023 |
| £ | £ |
| Within one year |
| Between one and five years |
| 17. | SECURED DEBTS |
| The company stands as guarantor for amounts advanced to group companies by the National Westminster Bank PLC. Accordingly the National Westminster Bank PLC holds fixed and floating charges over all of the company's assets. |
| 18. | PROVISIONS FOR LIABILITIES |
| 2024 | 2023 |
| £ | £ |
| Deferred tax | 101,682 | 126,686 |
| Deferred |
| tax |
| £ |
| Balance at 1 January 2024 |
| Deferred tax | (25,004 | ) |
| Balance at 31 December 2024 |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| 19. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 2024 | 2023 |
| value: | £ | £ |
| A Ordinary | 10p | 1,000 | 1,000 |
| B Ordinary | 10p | 1,000 | 1,000 |
| NIL | Preference Redeemable | £1 | - | 448,000 |
| 2,000 | 450,000 |
| During the period under review, all 448,000 £1 redeemable preference shares held by the parent company were redeemed. |
| 20. | RESERVES |
| Retained |
| earnings |
| £ |
| At 1 January 2024 |
| Deficit for the year | ( |
) |
| At 31 December 2024 |
| 21. | CONTINGENT LIABILITIES |
| In a previous accounting period HM Revenue and Customs opened enquiries into the Research and Development claims for the Corporation Tax periods ending 31st December 2020, 31st December 2021 and 31st December 2022. The directors had engaged tax consultants to defend these enquiries. After the reporting period HMRC determined that the Research and Development claims were valid and accepted. |
| 22. | RELATED PARTY DISCLOSURES |
| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. |
| Invoices totalling £85,766 (2023: £31,118) were raised to subsidiaries in the same group. At the balance sheet date the amount outstanding was £10,505 (2023: £7,763), included in trade and other debtor. |
| Invoices totalling £128,452 (2023: £84,867) were received from subsidiaries in the same group. At the balance sheet date the amount outstanding was £2,538 (2023: £41,704), included in trade and other creditors. |
| Invoices totalling £472,890 (2023: £448,040) were received from entities under common control. At the balance sheet date the amount outstanding was £39,580 (2023: £51,580), included in trade and other creditors. |
| Invoices totalling £4,412 (2023: Nil) were raised to entities under common control. At the balance sheet date the balance date the amount outstanding was £792 (2023: £50,177). |
| In the year the company written-off a loan due from a subsidiary of the same group. The amount written-off was £66,130 and has been included in the profit and loss account. |
| The company's parent company is TS Group International Limited, whose registered office is Sutherland House, 1759 London Road, Leigh-on-sea, Essex, SS9 2RZ. |
| TS Group International Limited draws up consolidated financial statements. |
| SYCHEM LIMITED (REGISTERED NUMBER: 04698955) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 DECEMBER 2024 |
| 22. | RELATED PARTY DISCLOSURES - continued |
| The ultimate controlling party is |
| 23. | AUDITOR LIABILITY LIMITATION AGREEMENT |
| On 30th July 2025 the directors resolved a Liability Limitation Agreement with it's Auditors. It was agreed that £2,000,000 represents a fair maximum to the auditors liability in the event of any one claim arising in respect of the audit. |
| 24. | SHARE-BASED PAYMENT TRANSACTIONS |
| The company's parent, TS Group International Limited created an equity-settled share option scheme which employees of the company can participate in. This scheme is an Enterprise Management Incentive Plan approved by HMRC. Each option has a maximum term of 10 years from the grant date, and each option vests only upon an exit event. Employees must remain in employment until the exit event to retain their share options. |
| 1,935 share options were granted on 16 September 2024 and all were outstanding at the balance sheet date. The valuation of the shares was approved by HMRC. Due to uncertainty around the date of an exit event and the market value of the shares at the grant date, no amount was recognised in the profit or loss in the current year in relation to the vesting of the shares, on the basis that a recognition of costs will occur once the exit condition and market value of shares are more certain. |